<

SANOFI-AVENTIS (EPA:SAN) Press Release: Sarclisa® (isatuximab) combination provides unprecedented median progression free survival in patients with relapsed multiple myeloma receiving a proteasome inhibitor therapy

Transparency directive : regulatory news

15/05/2022 09:30



Other stories

18/05/2022 12:12
18/05/2022 07:14
18/05/2022 10:11
18/05/2022 08:06
18/05/2022 10:22
18/05/2022 13:44
18/05/2022 12:24
18/05/2022 09:49
18/05/2022 11:52
18/05/2022 02:00
17/05/2022 17:14
18/05/2022 10:30
18/05/2022 00:54
18/05/2022 13:32
18/05/2022 13:17
17/05/2022 22:00
18/05/2022 10:23
18/05/2022 07:00
18/05/2022 09:00
17/05/2022 19:40
17/05/2022 20:45
18/05/2022 10:34
18/05/2022 08:44
17/05/2022 20:22
16/05/2022 14:41
18/05/2022 10:24
18/05/2022 12:07
18/05/2022 12:27
18/05/2022 11:25
18/05/2022 12:24
18/05/2022 01:02
17/05/2022 10:35
17/05/2022 17:00
17/05/2022 12:38
18/05/2022 12:59
17/05/2022 20:45
17/05/2022 08:36
17/05/2022 04:03